Overview

Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia (ALL) is a cancer of lymphocytes that live in the bone marrow, lymph nodes and spleen. ALL accounts for 20 percent of acute leukemia in adults, but is also the most common type of acute leukemia in children.

Our Approach to Acute Lymphoblastic Leukemia

UCSF is dedicated to delivering the most advanced treatment options for acute lymphoblastic leukemia (ALL) with care and compassion. Our goal is to achieve a cure. Standard treatments are effective in curing ALL in most adults, but for certain high-risk cases, we offer additional therapies, including stem cell transplants. Allogeneic transplantation – which uses stem cells or bone marrow from a tissue-matched donor – is our first choice, but if a compatible donor isn't available, we offer autologous transplantation, which uses cells collected from the patient.

We are also dedicated to discovering even better treatments for ALL through research. Interested patients may have the option to participate in clinical trials of potential new therapies.

Awards & recognition

  • usnews-neurology

    Best hospital in Northern California

  • n8-2x

    Ranked No. 12 in the nation for cancer care

  • 220-2x

    blood and marrow transplants performed each year

UCSF Health medical specialists have reviewed this information. It is for educational purposes only and is not intended to replace the advice of your doctor or other health care provider. We encourage you to discuss any questions or concerns you may have with your provider.

Share